BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17684048)

  • 21. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents.
    Coutant R; de Casson FB; Rouleau S; Douay O; Mathieu E; Gatelais F; Bouhours-Nouet N; Voinot C; Audran M; Limal JM
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6185-92. PubMed ID: 15579776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of growth hormone dose on bone maturation and puberty in children with idiopathic short stature.
    Crowe BJ; Rekers-Mombarg LT; Robling K; Wolka AM; Cutler GB; Wit JM;
    J Clin Endocrinol Metab; 2006 Jan; 91(1):169-75. PubMed ID: 16263828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
    Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia.
    Olney RC; Prickett TC; Espiner EA; Mackenzie WG; Duker AL; Ditro C; Zabel B; Hasegawa T; Kitoh H; Aylsworth AS; Bober MB
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E355-9. PubMed ID: 25387261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing short-statured children for growth hormone deficiency.
    Chemaitilly W; Trivin C; Souberbielle JC; Brauner R
    Horm Res; 2003; 60(1):34-42. PubMed ID: 12792152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Properties of spontaneous growth hormone secretory bursts and half-life of endogenous growth hormone in boys with idiopathic short stature. Genentech Collaborative Group.
    Veldhuis JDP6 ; Blizzard RM; Rogol AD; Martha PM; Kirkland JL; Sherman BM
    J Clin Endocrinol Metab; 1992 Apr; 74(4):766-73. PubMed ID: 1548338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
    Bouhours-Nouet N; Gatelais F; Boux de Casson F; Rouleau S; Coutant R
    J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal progression of testicular size in boys with idiopathic short stature and isolated growth hormone deficiency treated with growth hormone: experience from the KIGS.
    Lindgren AC; Chatelain P; Lindberg A; Price DA; Ranke MB; Reiter EO; Wilton P;
    Horm Res; 2002; 58(2):83-7. PubMed ID: 12207167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone treatment in adolescent males with idiopathic short stature: changes in body composition, protein, fat, and glucose metabolism.
    Hannon TS; Danadian K; Suprasongsin C; Arslanian SA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3033-9. PubMed ID: 17519313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-type Natriuretic Peptide: a novel biomarker of steroid induced bone toxicity in children with acute lymphoblastic leukemia (ALL).
    Prickett TC; Lyver A; Wilson R; Espiner EA; Sullivan MJ
    Peptides; 2012 Jul; 36(1):54-9. PubMed ID: 22564489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal determinants of pubertal growth.
    Delemarre-van de Waal HA; van Coeverden SC; Rotteveel J
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1521-6. PubMed ID: 11837509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone dose-dependent pubertal growth: a randomized trial in short children with low growth hormone secretion.
    Albertsson-Wikland K; Kriström B; Lundberg E; Aronson AS; Gustafsson J; Hagenäs L; Ivarsson SA; Jonsson B; Ritzén M; Tuvemo T; Westgren U; Westphal O; Aman J
    Horm Res Paediatr; 2014; 82(3):158-70. PubMed ID: 25170833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in growth and body composition during puberty: III. Influence of maturation, gender, body composition, fat distribution, aerobic fitness, and energy expenditure on nocturnal growth hormone release.
    Roemmich JN; Clark PA; Mai V; Berr SS; Weltman A; Veldhuis JD; Rogol AD
    J Clin Endocrinol Metab; 1998 May; 83(5):1440-7. PubMed ID: 9589636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum insulin-like factor 3 levels during puberty in healthy boys and boys with Klinefelter syndrome.
    Wikström AM; Bay K; Hero M; Andersson AM; Dunkel L
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4705-8. PubMed ID: 16926256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature.
    Gascoin-Lachambre G; Trivin C; Brauner R; Souberbielle JC
    Growth Horm IGF Res; 2007 Jun; 17(3):194-200. PubMed ID: 17321775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overnight growth hormone concentrations are usually normal in pubertal children with idiopathic short stature--a Clinical Research Center study.
    Rose SR; Municchi G; Barnes KM; Cutler GB
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1063-8. PubMed ID: 8772577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study.
    Shalet SM; Shavrikova E; Cromer M; Child CJ; Keller E; Zapletalová J; Moshang T; Blum WF; Chipman JJ; Quigley CA; Attanasio AF
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4124-9. PubMed ID: 12970274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.